4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000084
CFO and Treasurer sold 2,285 shares at an average $49.57 ($113,263)
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · CFO and Treasurer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-19 | Sale : show line 1 in the form | −2,085 | $49.52 | $103,249 | 95,502 | D |
| 2021-08-19 | Sale : show line 2 in the form | −200 | $50.07 | $10,014 | 95,302 | D |
| Open-market sales · 2,285 sh · avg $49.57 · $113,263 | ||||||
Loading xslF345X03/wf-form4_162976465052657.xml…